Follow

Submissions from 2021

Cardiogenic Shock Working Group Global Summit: Case Presentation, Jacob Abraham and Vidang P. Nguyen

Portopulmonary rhapsody: everything you need to know about portopulmonary hypertension, Sophia Airhart

Experience in a blood conservation initiative in cardiac surgery, James Brevig, Ruyun Jin, and Matthew Ducsik

Cardiovascular care in unusual places—delivering value beyond bricks and mortar, Tyler J Gluckman

Cardiovascular involvement in COVID-19: The good, the bad, and the unknown, Tyler J Gluckman

Clinical care in a post-pandemic world: what we learned and where we go from here, Tyler J Gluckman

How will selected 2021 ACC clinical trial findings change our practice?, Tyler J Gluckman

Optimal LDL-cholesterol: Individualizing treatment using statins and nonstatin therapy, Tyler J Gluckman

Peer-to-peer quality programs that actually work, Tyler J Gluckman

Quality of care, appropriate use criteria, the ACC-NCDR Registry and professional code of ethics, Tyler J Gluckman

Same day discharge- what opportunities exist and why should I be doing it?, Tyler J Gluckman

What did we learn from COVID-19?, Tyler J Gluckman

Hyperbaric oxygen therapy: monoplace chamber, A Perez

Efforts and progress on key vascular quality measures, Alejandro Perez

Peripheral arterial disease: diagnosis and medical management, Alejandro Perez

Peripheral artery disease: basic principles for the wound care clinician, Alejandro Perez

Wound care local coverage determination, Alejandro Perez

Strategic interventional approach to femoropopliteal occlusive disease, Brant Ullery

Submissions from 2020

Dangerous liaisons in pulmonary hypertension, Sophia Airhart

Link

ACCEL Lite: Case Rates, Treatment, and Outcomes in AMI During the COVID-19 Pandemic, Alison Bailey, Joseph Edward Marine, Tyler J Gluckman, and Yuvraj Chowdhury

Link

Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: insights from the LightLab initiative, Hiram Bezerra, Luis Dallan, Gabriel Tensol, Jana Buccola, Jason R Wollmuth, John Lopez, Richard Rapoza, Nick West, Brian Bergmark, and Kevin Croce

Link

COVID-19 and the CV service line: practical approaches for an unprecedented pandemic—Part 1, Jerry Blackwell, Cathie Biga, Geoffrey Rose, Tyler J Gluckman, John Rebok, and Eugene Yang

Link

Digital service in a virtual era: connecting the dots to help your community and save the world without leaving your home, Andrew Burgie, Liam Elkind, Alison Grady, and Xiaoyan Huang

Building and implementing team-based care in a successful financial model, Tyler J Gluckman

Cardiovascular issues related to COVID-19, Tyler J Gluckman

Coming to grips with chronic heart failure - keeping up with best practices, Tyler J Gluckman

Link

COVID-19’s Impact on Non-Communicable Diseases – The Enormous Toll it Has Taken, Tyler J Gluckman

Link

COVID-19 Web Series Part 10: Cardiovascular Issues Related to COVID-19, Tyler J Gluckman

Cross-industry real-world evidence (RWE), Tyler J Gluckman

First do no harm—approaches to PPE and testing, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Late-breaking clinical trials III, Tyler J Gluckman

Leveraging technology for quality improvement—what would Alexa and Siri say?, Tyler J Gluckman

Link

New Payment Model for E/M Services: Benefits and Risks of One Level of Service, Tyler J Gluckman

Non-communicable Diseases and the Toll it has Taken, Tyler J Gluckman

Quality of care, appropriate utilization criteria, the ACC-NCDR and professional code of ethics, Tyler J Gluckman

Link

Remote Patient Monitoring to Help with Cardiovascular Prevention During the COVID-19 Pandemic, Tyler J Gluckman

We have a service line: now what?, Tyler J Gluckman

We started. Now we need to implement (and get paid for) these subspecialty clinics, Tyler J Gluckman

Link

Managing Chronic Disease During COVID-19: Views From the US and Europe, Tyler J Gluckman, Katie Berlacher, and Simon G. Ray

Link

Race, Ethnicity, & Social Determinants in COVID-19: An Expert Panel Discussion, Tyler J Gluckman, Clyde W. Yancy, and Shrilla Banerjee

Practicing Cardiology in Portland 2020: Amidst Covid, Protests and Fire, Xiaoyan Huang

Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: A Propensity-Matched Analysis of Real World Data, Eric B Kirker

Adoption of a Strategy of Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement is Associated with Fewer Neurologic Events in a Large Volume Center, Ethan C Korngold

Intravascular Lithotripsy for Peripheral Artery Disease and Vascular Access, Ethan C Korngold

Strategies for Aorto-Iliac CTO Crossing, Ethan C Korngold

Transcarotid TAVR: The best alternative, Ethan C Korngold

Link

The Impact of Local Heart Allocation on Post-Transplant Survival, Vidang P. Nguyen and T Dardas

Advanced symposium peripheral arterial disease: controversies in treatment, Alejandro Perez

Hyperbaric medicine hyperbaric oxygen therapy: monoplace chamber, Alejandro Perez

Peripheral artery disease: basic principles for the wound care clinician, Alejandro Perez

Updates in Venous Disease Management, Alejandro Perez

Vascular testing, know why provider wants testing, Alejandro Perez

Device selection in TEVAR, Brant Ullery

Grand Rounds: Spinal protection strategies in contemporary aortic surgery, Brant Ullery

Management of abdominal aortic aneurysms with hostile infrarenal necks, Brant Ullery

Nearly 30 years of EVAR: Contemporary insights on long-term durability, Brant Ullery

Peripheral artery disease: Patient treatment, selection and device options in vascular surgery, Brant Ullery

Practical tools as healthcare emerges from the pandemic, Brant Ullery

Role of TEVAR in acute aortic syndromes, Brant Ullery

Supporting ruptured abdominal aortic aneurysm cases, Brant Ullery

Technical challenges in the treatment of ruptured AAAs. How to salvage the opportunity for ruptured EVAR, Brant Ullery

TEVAR in the fragile aorta, Brant Ullery

Embolization: thrombus, air, other, Jason R Wollmuth

Faculty panel - Intelligent intervention. Complex case examples incorporating lessons from SYNTAX 2, Jason R Wollmuth

High risk PCI program implementation and protocol development, Jason R Wollmuth

Live case panelist, case 3 & 4, Jason R Wollmuth

Live case panelist, case 5 & 6, Jason R Wollmuth

Link

New Advances in Avoiding Complications - Single Site Access in Impella-Assisted CTO PCI, Jason R Wollmuth

Retrograde CTO PCI, Jason R Wollmuth

Revascularization, support, and unloading: past, present, and future directions – protect IV: the synergy of MCS and complete revascularization, Jason R Wollmuth

Side branch access, Jason R Wollmuth

Single access Impella, Jason R Wollmuth

Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth

Link

Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth

Understanding how the use of routine oct workflow changes physician decisions: LightLab insights, Jason R Wollmuth

Link

COVID-19 lessons learned from China: disease management, clinical research and health policy, Wenhong Zhang, Sten H. Vermund, Xiaoyan Huang, and Kevin Ye

Submissions from 2019

High Tech, Meet High Touch, James G Beckerman

50 Years of Heart Valve Replacement: Effect of Prosthesis Choice on Long-Term Outcomes, Anthony P Furnary

Pharmacologic therapies to improve HF outcomes, Jill M Gelow

A case study on many views on value: Aortic valve replacement, Tyler J Gluckman

Advances in Heart Failure Management: How Will Recent Guideline Change Impact Your Treatment Selections, Tyler J Gluckman

Advances in heart failure management: How will recent guideline changes impact your treatment selections?, Tyler J Gluckman

Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - Executive Summary What Has Changed?, Tyler J Gluckman

Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - We Should Have Left it Alone: JNC7 Was Just Fine, Tyler J Gluckman

Closing the stroke prevention gap in nonvalvular atrial fibrillation—Real world data and its impact on patient outcomes., Tyler J Gluckman

How Can ACCorg Help You Implement Cholesterol Guidelines in Your Practice, Tyler J Gluckman

How should my approach to high blood pressure change? Key takeaways from the guidelines and case-based blood pressure pearls, Tyler J Gluckman

How should my approach to hypertension change? Key Takeaways from the Guidelines and Case-based BP Pearls, Tyler J Gluckman

Interprofessional Heart Teams: What are They and Why do I Need Them?, Tyler J Gluckman

Intersection of Antiplatelets and Anticoagulants--What to do When a Patient Needs Both?, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Making the Most Out of ACCorg: Optimizing Your Experience with Your Digital Home, Tyler J Gluckman

Managing LDL-cholesterol with PCSK9 inhibitors: Identifying the patients, optimizing the outcomes, Tyler J Gluckman

Managing treatment gaps with PCSK9 inhibitors, Tyler J Gluckman

Meeting the triple (quadruple) aim: How do we collectively care for the patient? What does this mean for the health system?, Tyler J Gluckman

Overcoming Access Barriers and Practice Challenges to PCSK9 Inhibitor Implementation, Tyler J Gluckman

PCSK9 inhibitors: Addressing the unmet needs in hypercholesterolemia, Tyler J Gluckman

Pitfalls and challenges in the road to quality: Navigating and avoiding potholes, Tyler J Gluckman

Putting Your NCDR Registry to Work, Tyler J Gluckman